Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Kimmelman

Showing results (21-30 of 192) with videos related to

Pageof 20
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2007
Stable ethics: enrolling non-treatment-refractory volunteers in novel gene transfer trialsJonathan Kimmelman
The Hastings Center Report|February 14, 2009
Battling a thousand points of mightJonathan Kimmelman
Clinical Trials (London, England)|November 24, 2020
Commentary on Kahrass et al: The sublime inertia of informed consent language in early phase clinical trials involving patientsJonathan Kimmelman
Bioethics|September 25, 2020
Why IRBs should protect bystanders in human researchJonathan Kimmelman
Clinical Trials (London, England)|November 5, 2021
<i>Clinical Trials</i> to authors: Please pre-register your studies!Jonathan Kimmelman
Trials|September 25, 2012
A theoretical framework for early human studies: uncertainty, intervention ensembles, and boundariesJonathan Kimmelman
Clinical Trials (London, England)|August 2, 2019
Organ donor intervention trials and the ethical challenge of bystander organ recipientsJonathan Kimmelman
Nature Reviews. Genetics|February 19, 2008
The ethics of human gene transferJonathan Kimmelman
Nature Reviews. Clinical Oncology|December 21, 2019
Reply to 'Correcting the ASCO position on phase I clinical trials in cancer'Jonathan Kimmelman
Clinical Advances in Hematology & Oncology : H&O|December 14, 2018
Ethical issues in the development of oncology drugsJonathan Kimmelman
Pageof 20

Showing results (21-30 of 192) with videos related to

Sort By:
Pageof 20
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2007
Stable ethics: enrolling non-treatment-refractory volunteers in novel gene transfer trialsJonathan Kimmelman
The Hastings Center Report|February 14, 2009
Battling a thousand points of mightJonathan Kimmelman
Clinical Trials (London, England)|November 24, 2020
Commentary on Kahrass et al: The sublime inertia of informed consent language in early phase clinical trials involving patientsJonathan Kimmelman
Bioethics|September 25, 2020
Why IRBs should protect bystanders in human researchJonathan Kimmelman
Clinical Trials (London, England)|November 5, 2021
<i>Clinical Trials</i> to authors: Please pre-register your studies!Jonathan Kimmelman
Trials|September 25, 2012
A theoretical framework for early human studies: uncertainty, intervention ensembles, and boundariesJonathan Kimmelman
Clinical Trials (London, England)|August 2, 2019
Organ donor intervention trials and the ethical challenge of bystander organ recipientsJonathan Kimmelman
Nature Reviews. Genetics|February 19, 2008
The ethics of human gene transferJonathan Kimmelman
Nature Reviews. Clinical Oncology|December 21, 2019
Reply to 'Correcting the ASCO position on phase I clinical trials in cancer'Jonathan Kimmelman
Clinical Advances in Hematology & Oncology : H&O|December 14, 2018
Ethical issues in the development of oncology drugsJonathan Kimmelman
Pageof 20